Care providers and patients are now speaking out after a First Alert 4 investigation Monday revealed safety concerns with IV ...

He says the company making new IV pumps for BJC facilities should be “sued into oblivion” if they have harmed patients in ...

In its fourth quarter 2024 investor letter, Artisan Mid Cap Value Fund emphasized stocks such as Baxter International Inc. (NYSE:BAX). Baxter International Inc. (NYSE:BAX) is a Medical Instruments ...

A financial advisory firm has been bought by a major industry player. Robertson Baxter, based in Shepley, near Huddersfield, has been acquired by Benchmark Capital, part of global asset manager ...

Baxter International Inc., through its subsidiaries ... It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic ...

It does not necessarily reflect the view of The Herald. NATHAN Baxter wants to play his way to a new contract with Bolton Wanderers. The goalkeeper, who retuned to the starting line-up for the ...

We may earn an affiliate commission from links. The best tubing mascaras give length and lift to your lashes with the added benefit of easy makeup removal. While TikTok introduced late millennials ...

IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown ...

And in the second half of 2024, hospitals couldn’t get enough IV fluid due to damage caused by Hurricane Helene to a Baxter factory in North Carolina that manufactures approximately 60% of IV ...

¨ Fee paid previously with preliminary materials. ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 We are pleased to invite you to our Annual ...

Baxter International paid former Chair, President and CEO José Almeida $18.1 million in 2024, his ninth and final year leading the medical device manufacturer. That’s according to a new compensation ...